David C Marek insider trades: Myovant Sciences (MYOV) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 18, 2023 | MYOV | ↓ Sell | 8,037 | $26.89 | $216K | Direct | Jan 20, 2023 (2d) |
| Oct 18, 2022 | MYOV | ↓ Sell | 11,156 | $25.20 | $281K | Direct | Oct 20, 2022 (2d) |
| Jul 18, 2022 | MYOV | ↓ Sell | 11,164 | $12.87 | $144K | Direct | Jul 20, 2022 (2d) |
| Apr 19, 2022 | MYOV | ↓ Sell | 24,594 | $10.45 | $257K | Direct | Apr 21, 2022 (2d) |
| Jan 19, 2022 | MYOV | ↓ Sell | 19,882 | $14.68 | $292K | Direct | Jan 21, 2022 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David C Marek's insider trades
David C Marek is Principal Executive Officer at Myovant Sciences (MYOV). Since Jan 19, 2022, David has reported no open-market purchases and 5 sales worth $1.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), shares returned to the company (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MYOV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.